{"title":"RETRACTION: Circular RNA circFBXO11 Modulates Hepatocellular Carcinoma Progress and Oxaliplatin Resistance Through miR-605/FOXO3/ABCB1 Axis","authors":"","doi":"10.1111/jcmm.70355","DOIUrl":null,"url":null,"abstract":"<p><b>RETRACTION</b>: J. Li, X. Qin, R. Wu, L. Wan, L. Zhang, and R. Liu, “Circular RNA circFBXO11 Modulates Hepatocellular Carcinoma Progress and Oxaliplatin Resistance Through miR-605/FOXO3/ABCB1 Axis,” <i>Journal of Cellular and Molecular Medicine</i> 24, no. 9 (2020): 5152–5161, https://doi.org/10.1111/jcmm.15162.</p><p>The above article, published online on 28 March 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu, The Foundation for Cellular and Molecular Medicine and John Wiley and Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed implausible similarities between Figure 2G NC of this study and another article published earlier in the same year by a different group of authors in a different scientific context, suggesting that the images were likely obtained from the same flow-cytometry data set. The explanation and the partial raw data shared by the authors were deemed insufficient to address these concerns. Thus, the editors have lost confidence in the presented data and consider the conclusions of this manuscript substantially compromised.</p>","PeriodicalId":101321,"journal":{"name":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","volume":"29 1","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11724332/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF CELLULAR AND MOLECULAR MEDICINE","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jcmm.70355","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
RETRACTION: J. Li, X. Qin, R. Wu, L. Wan, L. Zhang, and R. Liu, “Circular RNA circFBXO11 Modulates Hepatocellular Carcinoma Progress and Oxaliplatin Resistance Through miR-605/FOXO3/ABCB1 Axis,” Journal of Cellular and Molecular Medicine 24, no. 9 (2020): 5152–5161, https://doi.org/10.1111/jcmm.15162.
The above article, published online on 28 March 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu, The Foundation for Cellular and Molecular Medicine and John Wiley and Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed implausible similarities between Figure 2G NC of this study and another article published earlier in the same year by a different group of authors in a different scientific context, suggesting that the images were likely obtained from the same flow-cytometry data set. The explanation and the partial raw data shared by the authors were deemed insufficient to address these concerns. Thus, the editors have lost confidence in the presented data and consider the conclusions of this manuscript substantially compromised.
引用本文:李军,秦晓霞,吴瑞丽,万丽丽,张丽,刘瑞华,“circFBXO11通过miR-605/FOXO3/ABCB1轴调控肝癌进展和奥沙利铂耐药”,《细胞与分子医学杂志》,第24期,第2期。9 (2020): 5152-5161, https://doi.org/10.1111/jcmm.15162。上述文章于2020年3月28日在线发表在Wiley在线图书馆(wileyonlinelibrary.com)上,经该杂志主编Stefan Constantinescu、细胞和分子医学基金会以及John Wiley and Sons Ltd.同意撤回。在对第三方提出的担忧进行调查后,该研究的图2G NC与同年早些时候由另一组作者在不同科学背景下发表的另一篇文章之间存在令人难以置信的相似性,这表明这些图像可能来自相同的流式细胞术数据集。作者的解释和部分原始数据被认为不足以解决这些问题。因此,编辑对所提交的数据失去了信心,并认为这篇手稿的结论在很大程度上受到了损害。
期刊介绍:
The Journal of Cellular and Molecular Medicine serves as a bridge between physiology and cellular medicine, as well as molecular biology and molecular therapeutics. With a 20-year history, the journal adopts an interdisciplinary approach to showcase innovative discoveries.
It publishes research aimed at advancing the collective understanding of the cellular and molecular mechanisms underlying diseases. The journal emphasizes translational studies that translate this knowledge into therapeutic strategies. Being fully open access, the journal is accessible to all readers.